Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria".

Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS, Le Manach C, Paquet T, Gonzàlez Cabrera D, Nchinda AT, de Kock C, Wiesner L, Denti P, Waterson D, Blasco B, Leroy D, Witty MJ, Donini C, Duffy J, Wittlin S, White KL, Charman SA, Jiménez-Díaz MB, Angulo-Barturen I, Herreros E, Gamo FJ, Rochford R, Mancama D, Coetzer TL, van der Watt ME, Reader J, Birkholtz LM, Marsh KC, Solapure SM, Burke JE, McPhail JA, Vanaerschot M, Fidock DA, Fish PV, Siegl P, Smith DA, Wirjanata G, Noviyanti R, Price RN, Marfurt J, Silue KD, Street LJ, Chibale K.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01941-18. doi: 10.1128/AAC.01941-18. Print 2018 Nov. No abstract available.

2.

Investigating Sulfoxide-to-Sulfone Conversion as a Prodrug Strategy for a Phosphatidylinositol 4-Kinase Inhibitor in a Humanized Mouse Model of Malaria.

Gibhard L, Njoroge M, Paquet T, Brunschwig C, Taylor D, Lawrence N, Abay E, Wittlin S, Wiesner L, Street LJ, Chibale K, Basarab GS.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e00261-18. doi: 10.1128/AAC.00261-18. Print 2018 Dec.

3.

UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.

Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS, Le Manach C, Paquet T, Cabrera DG, Nchinda AT, de Kock C, Wiesner L, Denti P, Waterson D, Blasco B, Leroy D, Witty MJ, Donini C, Duffy J, Wittlin S, White KL, Charman SA, Jiménez-Díaz MB, Angulo-Barturen I, Herreros E, Gamo FJ, Rochford R, Mancama D, Coetzer TL, van der Watt ME, Reader J, Birkholtz LM, Marsh KC, Solapure SM, Burke JE, McPhail JA, Vanaerschot M, Fidock DA, Fish PV, Siegl P, Smith DA, Wirjanata G, Noviyanti R, Price RN, Marfurt J, Silue KD, Street LJ, Chibale K.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00012-18. doi: 10.1128/AAC.00012-18. Print 2018 Sep. Erratum in: Antimicrob Agents Chemother. 2018 Oct 24;62(11):.

4.

The In Vitro and In Vivo Effects of Hypoxis hemerocallidea on Indinavir Pharmacokinetics: Modulation of Efflux.

Havenga K, Abay E, Wiesner L, Viljoen A, Steyn D, Hamman J.

Planta Med. 2018 Aug;84(12-13):895-901. doi: 10.1055/a-0607-2743. Epub 2018 Apr 19.

PMID:
29672818
5.

Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ null Mouse Model of Malaria.

Nchinda AT, Le Manach C, Paquet T, Gonzàlez Cabrera D, Wicht KJ, Brunschwig C, Njoroge M, Abay E, Taylor D, Lawrence N, Wittlin S, Jiménez-Díaz MB, Santos Martínez M, Ferrer S, Angulo-Barturen I, Lafuente-Monasterio MJ, Duffy J, Burrows J, Street LJ, Chibale K.

J Med Chem. 2018 May 10;61(9):4213-4227. doi: 10.1021/acs.jmedchem.8b00382. Epub 2018 Apr 27.

PMID:
29665687
6.

Diagnostic Value of Serum Urokinase-Type Plasminogen Activator Receptor in Children With Acute Appendicitis.

Oztan MO, Aksoy Gokmen A, Arslan FD, Cakir E, Sayan A, Abay E, Kaya S, Koyluoglu G.

Pediatr Emerg Care. 2018 Jan 11. doi: 10.1097/PEC.0000000000001416. [Epub ahead of print]

PMID:
29324635
7.

Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies.

Wilson CR, Gessner RK, Moosa A, Seldon R, Warner DF, Mizrahi V, Soares de Melo C, Simelane SB, Nchinda A, Abay E, Taylor D, Njoroge M, Brunschwig C, Lawrence N, Boshoff HIM, Barry CE 3rd, Sirgel FA, van Helden P, Harris CJ, Gordon R, Ghidelli-Disse S, Pflaumer H, Boesche M, Drewes G, Sanz O, Santos G, Rebollo-Lopez MJ, Urones B, Selenski C, Lafuente-Monasterio MJ, Axtman M, Lelièvre J, Ballell L, Mueller R, Street LJ, Ghorpade SR, Chibale K.

J Med Chem. 2017 Dec 28;60(24):10118-10134. doi: 10.1021/acs.jmedchem.7b01347. Epub 2017 Dec 7.

8.

Who Is the Preferred Tutor in Clinical Skills Training: Physicians, Nurses, or Peers?

Abay EŞ, Turan S, Odabaşı O, Elçin M.

Teach Learn Med. 2017 Jul-Sep;29(3):247-254. doi: 10.1080/10401334.2016.1274262. Epub 2017 Mar 15.

PMID:
28296513
9.

An umbilical venous catheter complication presented as acute abdomen: case report.

Oztan MO, Ilhan O, Abay E, Koyluoglu G.

Arch Argent Pediatr. 2016 Dec 1;114(6):e429. doi: 10.5546/aap.2016.eng.e429. Spanish, English.

10.

In Vitro and In Vivo Pharmacokinetics of Aminoalkylated Diarylpropanes NP085 and NP102.

Gibhard L, Pravin K, Abay E, Wilhelm A, Swart K, Lawrence N, Khoury R, van der Westhuizen J, Smith P, Wiesner L.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3065-9. doi: 10.1128/AAC.02104-15. Print 2016 May.

11.

Herb-Drug Pharmacokinetic Interactions: Transport and Metabolism of Indinavir in the Presence of Selected Herbal Products.

Calitz C, Gouws C, Viljoen J, Steenekamp J, Wiesner L, Abay E, Hamman J.

Molecules. 2015 Dec 10;20(12):22113-27. doi: 10.3390/molecules201219838.

12.

Evaluation of Isolated Fractions of Aloe vera Gel Materials on Indinavir Pharmacokinetics: In vitro and in vivo Studies.

Wallis L, Malan M, Gouws C, Steyn D, Ellis S, Abay E, Wiesner L, Otto DP, Hamman J.

Curr Drug Deliv. 2016;13(3):471-80.

PMID:
26568138
13.

Syntheses and in Vitro Antiplasmodial Activity of Aminoalkylated Chalcones and Analogues.

Wilhelm A, Kendrekar P, Noreljaleel AE, Abay ET, Bonnet SL, Wiesner L, de Kock C, Swart KJ, van der Westhuizen JH.

J Nat Prod. 2015 Aug 28;78(8):1848-58. doi: 10.1021/acs.jnatprod.5b00114. Epub 2015 Aug 3.

PMID:
26235033
14.

Efficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model.

Abay ET, van der Westuizen JH, Swart KJ, Gibhard L, Lawrence N, Dambuza N, Wilhelm A, Pravin K, Wiesner L.

Malar J. 2015 Jan 6;14:8. doi: 10.1186/1475-2875-14-8.

15.

Synthesis and in vitro and in vivo pharmacological evaluation of new 4-aminoquinoline-based compounds.

Tukulula M, Njoroge M, Abay ET, Mugumbate GC, Wiesner L, Taylor D, Gibhard L, Norman J, Swart KJ, Gut J, Rosenthal PJ, Barteau S, Streckfuss J, Kameni-Tcheudji J, Chibale K.

ACS Med Chem Lett. 2013 Oct 1;4(12):1198-202. doi: 10.1021/ml400311r. eCollection 2013 Dec 12.

16.

The development and validation of an LC-MS/MS method for the determination of a new anti-malarial compound (TK900D) in human whole blood and its application to pharmacokinetic studies in mice.

Abay ET, van der Westhuizen JH, Swart KJ, Gibhard L, Tukulula M, Chibale K, Wiesner L.

Malar J. 2014 Jan 31;13:42. doi: 10.1186/1475-2875-13-42.

17.

The impact of physical and psychological comorbid conditions on the quality of life of patients with acute myocardial infarction: a multi-center, cross-sectional observational study from Turkey.

Sertoz OO, Aydemir O, Gulpek D, Elbi H, Ozenli Y, Yilmaz A, Ozan E, Atesci F, Abay E, Semiz M, Direk N, Hocaoglu C, Elyas Z, Ozmen M, Ozen S, Konuk N.

Int J Psychiatry Med. 2013;45(2):97-109.

PMID:
23977815
18.

Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?

Ozen H, Akyol F, Toktas G, Eskicorapci S, Unluer E, Kuyumcuoglu U, Abay E, Cureklibatur I, Sengoz M, Yalcin V, Akpinar H, Zorlu F, Sengor F, Karaman I.

J Urol. 2010 Aug;184(2):519-24. doi: 10.1016/j.juro.2010.03.137. Epub 2010 Jun 17.

PMID:
20620411
19.

Acute stress disorder and post-traumatic stress disorder following traumatic amputation.

Copuroglu C, Ozcan M, Yilmaz B, Gorgulu Y, Abay E, Yalniz E.

Acta Orthop Belg. 2010 Feb;76(1):90-3.

PMID:
20306971
20.

Amisulpride-induced neuroleptic malignant syndrome.

Abay E, Kose R.

J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):488-9. No abstract available.

PMID:
18070872
21.

[Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].

Güdücü F, Caliyurt O, Vardar E, Tuğlu C, Abay E.

Turk Psikiyatri Derg. 2005 Winter;16(4):245-51. Turkish.

22.
23.

Acute disseminated encephalomyelitis presenting as conversion disorder.

Abay E, Balci K, Ates I.

J Neuropsychiatry Clin Neurosci. 2005 Spring;17(2):259-60. No abstract available.

PMID:
15939989
24.

Effects of propofol on electroconvulsive therapy seizure duration.

Caliyurt O, Vardar E, Tuglu C, Abay E.

Can J Psychiatry. 2004 Oct;49(10):707-8. No abstract available.

PMID:
15560320
25.

Clastogenicity of selective serotonin-reuptake inhibitors.

Bozkurt G, Abay E, Ates I, Karabogaz G, Ture M, Savran FO, Palanduz S, Temocin K, Algunes C.

Mutat Res. 2004 Mar 14;558(1-2):137-44.

PMID:
15036127
26.

Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder.

Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E.

Psychopharmacology (Berl). 2003 Dec;170(4):429-33. Epub 2003 Aug 30.

PMID:
12955291
27.

Seasonal affective disorder in eight groups in Turkey: a cross-national perspective.

Elbi H, Noyan A, Korukoğlu S, Unal S, Bekaroğlu M, Oğuzhanoğlu N, Türköz N, Abay E, Kumbasar H, Yurdakul S.

J Affect Disord. 2002 Jun;70(1):77-84.

PMID:
12113922
28.

Evaluation of dysthymic disorder with technetium-99 m hexamethylpropylene amine oxime brain single-photon emission tomography.

Sarikaya A, Karaşin E, Cermik TF, Abay E, Berkarda S.

Eur J Nucl Med. 1999 Mar;26(3):260-4.

PMID:
10079317
29.

Multiple sclerosis presenting as an intramedullary cervical cord tumor.

Lammoglia FJ, Short SR, Sweet DE, Pay N, Abay EA 2nd.

Kans Med. 1989 Jul;90(7):219-21, 228.

PMID:
2761166
30.
31.

Pharmacological studies on the application, disposition, and release of neurotensin in the spinal cord.

Yaksh TL, Schmauss C, Micevych PE, Abay EO, Go VL.

Ann N Y Acad Sci. 1982;400:228-43. No abstract available.

PMID:
6188399
32.

Pineal tumors in children and adolescents. Treatment by CSF shunting and radiotherapy.

Abay EO 2nd, Laws ER Jr, Grado GL, Bruckman JE, Forbes GS, Gomez MR, Scott M.

J Neurosurg. 1981 Dec;55(6):889-95.

PMID:
7299463

Supplemental Content

Support Center